These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 22803644

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. How future tumor necrosis factor antagonists and other compounds will meet the remaining challenges in Crohn's disease.
    Sandborn WJ.
    Rev Gastroenterol Disord; 2004; 4 Suppl 3():S25-33. PubMed ID: 15583528
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Elective switching from infliximab to adalimumab in stable Crohn's disease.
    Hoentjen F, Haarhuis BJ, Drenth JP, de Jong DJ.
    Inflamm Bowel Dis; 2013; 19(4):761-6. PubMed ID: 23446337
    [Abstract] [Full Text] [Related]

  • 29. [Treatment with anti-TNFalpha agents in Crohn's disease: what drug we have to use and when?].
    Gomollón F, López SG.
    Acta Gastroenterol Latinoam; 2008 Jun; 38(2):133-45. PubMed ID: 18697408
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Autoimmune hepatitis induced by infliximab in a patient with Crohn's disease with no relapse after switching to adalimumab.
    Cravo M, Silva R, Serrano M.
    BioDrugs; 2010 Dec 14; 24 Suppl 1():25-7. PubMed ID: 21175232
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Infliximab and adalimumab-induced psoriasis in Crohn's disease: a paradoxical side effect.
    Iborra M, Beltrán B, Bastida G, Aguas M, Nos P.
    J Crohns Colitis; 2011 Apr 14; 5(2):157-61. PubMed ID: 21453886
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Effectiveness of anti-TNF alpha antibodies in treatment of fistulizing Crohn's disease].
    Rozpondek P, Zwolińska-Wcisło M, Przybylska M, Mach T.
    Przegl Lek; 2011 Apr 14; 68(9):602-5. PubMed ID: 22335009
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Successfully multiple pregnancies in Crohn's disease under long-term treatment with adalimumab.
    Tursi A.
    Acta Gastroenterol Belg; 2013 Jun 14; 76(2):264-5. PubMed ID: 23898572
    [No Abstract] [Full Text] [Related]

  • 40. [Adalimumab in infliximab refractory Crohn's disease -- the next generation of anti-TNF-alpha-therapy?].
    Heidemann J, Kucharzik T.
    Z Gastroenterol; 2005 Jul 14; 43(7):689-90. PubMed ID: 16001352
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.